544 related articles for article (PubMed ID: 24521297)
21. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.
Hamano N; Negishi Y; Fujisawa A; Manandhar M; Sato H; Katagiri F; Nomizu M; Aramaki Y
Int J Pharm; 2012 May; 428(1-2):114-7. PubMed ID: 22421321
[TBL] [Abstract][Full Text] [Related]
22. Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles.
Gao H; Yang Z; Zhang S; Pang Z; Jiang X
J Drug Target; 2014 Jun; 22(5):450-9. PubMed ID: 24512500
[TBL] [Abstract][Full Text] [Related]
23. Arginine-Glycine-Aspartic Acid-Modified Lipid-Polymer Hybrid Nanoparticles for Docetaxel Delivery in Glioblastoma Multiforme.
Shi K; Zhou J; Zhang Q; Gao H; Liu Y; Zong T; He Q
J Biomed Nanotechnol; 2015 Mar; 11(3):382-91. PubMed ID: 26307822
[TBL] [Abstract][Full Text] [Related]
24. A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment.
Zhang CX; Zhao WY; Liu L; Ju RJ; Mu LM; Zhao Y; Zeng F; Xie HJ; Yan Y; Lu WL
Oncotarget; 2015 Oct; 6(32):32681-700. PubMed ID: 26418720
[TBL] [Abstract][Full Text] [Related]
25. Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy.
Miao D; Jiang M; Liu Z; Gu G; Hu Q; Kang T; Song Q; Yao L; Li W; Gao X; Sun M; Chen J
Mol Pharm; 2014 Jan; 11(1):90-101. PubMed ID: 24295590
[TBL] [Abstract][Full Text] [Related]
26. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
Xin H; Sha X; Jiang X; Zhang W; Chen L; Fang X
Biomaterials; 2012 Nov; 33(32):8167-76. PubMed ID: 22889488
[TBL] [Abstract][Full Text] [Related]
27. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
[TBL] [Abstract][Full Text] [Related]
28. Combined integrin α
Qi N; Zhang S; Zhou X; Duan W; Gao D; Feng J; Li A
J Nanobiotechnology; 2021 Dec; 19(1):446. PubMed ID: 34949198
[TBL] [Abstract][Full Text] [Related]
29. High Precision Imaging of Microscopic Spread of Glioblastoma with a Targeted Ultrasensitive SERRS Molecular Imaging Probe.
Huang R; Harmsen S; Samii JM; Karabeber H; Pitter KL; Holland EC; Kircher MF
Theranostics; 2016; 6(8):1075-84. PubMed ID: 27279902
[TBL] [Abstract][Full Text] [Related]
30. Enhanced Antiglioblastoma Efficacy of Neovasculature and Glioma Cells Dual Targeted Nanoparticles.
Lv L; Jiang Y; Liu X; Wang B; Lv W; Zhao Y; Shi H; Hu Q; Xin H; Xu Q; Gu Z
Mol Pharm; 2016 Oct; 13(10):3506-3517. PubMed ID: 27636161
[TBL] [Abstract][Full Text] [Related]
31. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q
Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a bispecific biological drug designed to simultaneously target glioblastoma and its neovasculature in the brain.
Oh S; Tsai AK; Ohlfest JR; Panoskaltsis-Mortari A; Vallera DA
J Neurosurg; 2011 Jun; 114(6):1662-71. PubMed ID: 21294620
[TBL] [Abstract][Full Text] [Related]
33. Single peptide ligand-functionalized uniform hollow mesoporous silica nanoparticles achieving dual-targeting drug delivery to tumor cells and angiogenic blood vessel cells.
Liu Y; Chen Q; Xu M; Guan G; Hu W; Liang Y; Zhao X; Qiao M; Chen D; Liu H
Int J Nanomedicine; 2015; 10():1855-67. PubMed ID: 25834425
[TBL] [Abstract][Full Text] [Related]
34. Upconversion nanoparticles conjugated with Gd(3+) -DOTA and RGD for targeted dual-modality imaging of brain tumor xenografts.
Jin J; Xu Z; Zhang Y; Gu YJ; Lam MH; Wong WT
Adv Healthc Mater; 2013 Nov; 2(11):1501-12. PubMed ID: 23630101
[TBL] [Abstract][Full Text] [Related]
35. Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects.
Lin XM; Shi XX; Xiong L; Nie JH; Ye HS; Du JZ; Liu J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638961
[TBL] [Abstract][Full Text] [Related]
36. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer.
Yao J; Feng J; Gao X; Wei D; Kang T; Zhu Q; Jiang T; Wei X; Chen J
Biomaterials; 2017 Jan; 113():1-17. PubMed ID: 27794222
[TBL] [Abstract][Full Text] [Related]
37. Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.
Wu J; Zhao J; Zhang B; Qian Y; Gao H; Yu Y; Wei Y; Yang Z; Jiang X; Pang Z
Int J Nanomedicine; 2014; 9():5261-71. PubMed ID: 25419130
[TBL] [Abstract][Full Text] [Related]
38. Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles.
Chu Y; Chen N; Yu H; Mu H; He B; Hua H; Wang A; Sun K
Int J Nanomedicine; 2017; 12():1353-1368. PubMed ID: 28260884
[TBL] [Abstract][Full Text] [Related]
39. RGD-labeled USPIO inhibits adhesion and endocytotic activity of alpha v beta3-integrin-expressing glioma cells and only accumulates in the vascular tumor compartment.
Kiessling F; Huppert J; Zhang C; Jayapaul J; Zwick S; Woenne EC; Mueller MM; Zentgraf H; Eisenhut M; Addadi Y; Neeman M; Semmler W
Radiology; 2009 Nov; 253(2):462-9. PubMed ID: 19789239
[TBL] [Abstract][Full Text] [Related]
40. RGD peptide conjugation results in enhanced antitumor activity of PD0325901 against glioblastoma by both tumor-targeting delivery and combination therapy.
Hou J; Diao Y; Li W; Yang Z; Zhang L; Chen Z; Wu Y
Int J Pharm; 2016 May; 505(1-2):329-40. PubMed ID: 27085642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]